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Objective: New techniques for minimally invasive coronary artery bypass
grafting have recently emerged. The purpose of this study was to determine
the safety and efficacy of Port-Access (Heartport, Inc., Redwood City, Calif.)
coronary revascularization and to evaluate with angiography the early graft
patency rate with this new approach. Methods: From October 1996 to May
1997, 31 patients underwent Port-Access coronary artery bypass grafting
with an anterior minithoracotomy and endovascular-occlusion cardiopul-
monary bypass. There were 26 men and 5 women with a mean age of 62
years (range 42 to 82 years). Fifteen patients underwent single bypass; 12
patients underwent double bypass, and 4 patients underwent triple bypass.
Bypass conduits included the left internal thoracic artery (n 5 30), right
internal thoracic artery (n 5 2), radial artery (n 5 10), and saphenous vein
(n 5 6). Three sequential grafts were used. Angiographic studies of the
bypass grafts were performed in 27 of 31 patients (87%). Results: There were
no deaths, neurologic deficits, myocardial infarctions, or aortic dissections.
Conversion to sternotomy was not required in any case. There were two
reoperations for bleeding, one reoperation for tamponade, and one reop-
eration for pulmonary embolus. Postoperative angiography revealed anas-
tomotic patency of the left internal thoracic artery to left anterior descend-
ing artery in 26 of 26 grafts (100%) with overall anastomotic patency in 43
of 44 grafts (97.7%). Conclusion: These results demonstrate that Port-
Access coronary artery bypass can be performed accurately and safely with
acceptable morbidity. This approach allows for multivessel revasculariza-
tion on an arrested, protected heart with excellent anastomotic precision
and reproducible early graft patency. (J Thorac Cardiovasc Surg 1998;115:
1101-10)
Recent advances in minimally invasive surgicaltechniques have revolutionized the fields of gen-
eral and thoracic surgery; however, methods of
minimally invasive cardiac surgery were slow to
develop. This was in part due to the high degree of
accuracy and precision required for cardiac opera-
tions as well as the need for cardiopulmonary bypass
(CPB) and myocardial protection for most cardiac
surgical procedures. For new techniques of mini-
mally invasive cardiac surgery to be widely applica-
ble, methods of less invasive extracorporeal perfu-
sion, aortic occlusion, and cardioplegia delivery had
to be developed.
The Port-Access (Heartport, Inc., Redwood City,
Calif.) technique involves a newly developed system
for endovascular CPB and myocardial protection
with cardioplegic arrest. This system uses femoral
arterial and venous access for CPB and a transfemo-
ral endoaortic balloon occlusion catheter for aortic
occlusion and cardioplegia delivery, allowing the
surgeon to perform bypass procedures on an ar-
rested, protected heart through a minithoracotomy
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incision. Anticipated advantages to the patient in-
clude avoidance of a median sternotomy, a smaller
incision and scar, less pain, an improved cosmetic
result, a shorter hospital stay and recovery time, and
a decrease in overall cost. Clearly, however, the
excellent long-term graft patency rates and minimal
morbidity and mortality rates associated with con-
ventional coronary artery bypass grafting (CABG)1-3
must not be compromised for the sake of patient
comfort, cosmesis, or cost containment. The pur-
pose of this study was therefore to determine the
safety and efficacy of Port-Access CABG and to
evaluate with angiography the early graft patency
rates with this new approach.
Patients and methods
Patients. Between October 1996 and May 1997, 31
patients underwent Port-Access CABG through an ante-
rior minithoracotomy. During this period no patient who
underwent Port-Access CABG was excluded from this
study, and no patient refused to undergo Port-Access
CABG because postoperative angiography would be re-
quired. There were 26 men and five women with a mean
age of 62 years (range 42 to 82 years). Fifteen patients
underwent single bypass, 12 patients underwent double
bypass, and 4 patients underwent triple bypass. Of the 31
patients, 29 received a left internal thoracic artery (LITA)
graft to the left anterior descending (LAD) coronary
artery through a left anterior minithoracotomy; one pa-
tient underwent grafting of the right internal thoracic
artery (RITA) to the right coronary artery (RCA) through
a right anterior minithoracotomy, and one patient under-
went LITA and RITA grafting with a left and right
anterior minithoracotomy. A radial artery (n 5 10),
saphenous vein (n 5 6), or sequential graft (n 5 3) was
used for multivessel procedures; the LITA served as the
site for the proximal anastomosis in all cases. Coronary
arteries bypassed included the LAD (n 5 30), diagonal
(n 5 4), circumflex (n 5 5), obtuse marginal (n 5 5),
ramus (n 5 2), RCA (n 5 3), posterolateral (n 5 1), and
posterior descending (n 5 1). All patients underwent
femoral cannulation and perfusion, aortic occlusion, and
cardioplegic arrest with the Port-Access endovascular
CPB system.
The patients in this series were evaluated before the
operation by the referring cardiologist and by one of four
cardiac surgeons trained in the Port-Access technique.
Patients with single-vessel coronary artery disease who
were not candidates for angioplasty were evaluated for the
Port-Access approach. Patients with multivessel disease
were considered selectively, depending on the number of
grafts required and the proposed distal sites. Exclusion
criteria for the Port-Access approach included evidence of
significant arterial or venous peripheral vascular disease
or evidence of significant atherosclerotic disease of the
aorta. The presence of significant vascular disease may
preclude safe femoral artery cannulation, retrograde per-
fusion, or placement of the endoaortic occlusion catheter
in the ascending aorta and may result in a potential risk
for retrograde aortic dissection or stroke.
A variety of methods were used to evaluate the periph-
eral vascular system, including history and physical exam-
ination. Approximately one half of the patients had an
aortogram with runoff performed at the time of coronary
angiography. Direct palpation of the common femoral
artery was performed at the time of the groin dissection in
all patients. Two patients found to have moderate disease
of the femoral artery at the time of groin dissection
underwent angiography on the operating room table using
a 5F pigtail catheter via the femoral artery before pro-
ceeding with the chest incision. Angiography demon-
strated minimal atherosclerotic disease of the aortic bifur-
cation, iliac artery, and common femoral arteries; both
Fig. 1. Under fluoroscopy, dilution contrast solution is injected through the endosinus catheter (ESC) and
its position is confirmed with a coronary sinus angiogram (CSA). The TEE probe is also seen.
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patients underwent successful Port-Access CABG. In
addition, intraoperative transesophageal echocardiogra-
phy (TEE) was used in all cases for evaluation of the
thoracic aorta before femoral cannulation and insertion of
the endoaortic occlusion balloon.
Preoperative risk factors included hypertension in 19
patients (61%), diabetes in 10 patients (32%), smoking in
6 patients (19%), obesity in 4 patients (13%), hypercho-
lesterolemia in 13 patients (42%), chronic renal failure in
1 patient (3%), stroke in 2 patients (6%), and myocardial
infarction in 10 patients (32%). The mean preoperative
ejection fraction was 51%. Eleven patients had previously
undergone angioplasty (35%) with a mean time between
angioplasty and surgery of 9.6 months. Five of these
patients had coronary stents placed, and seven patients
underwent more than one angioplasty procedure. One
patient underwent angioplasty and stenting of a mid-
circumflex lesion and was referred for Port-Access LITA
to LAD coronary artery bypass. One patient who under-
went a single bypass procedure had a previous bypass
procedure through a median sternotomy.
Operative technique. After induction of general anes-
thesia, patients were intubated with a double-lumen en-
dotracheal tube. Arterial pressure was monitored in both
Fig. 2. Drawings show (A) a left anterior minithoracotomy; the fourth costal cartilage has been removed,
exposing the LITA immediately below. B, The midportion of the LITA is used as the source of inflow for
additional conduits. Initially the LITA is not divided but is occluded proximally and distally. For each
proximal anastomosis, a 3 to 4 mm longitudinal incision is made in the lateral surface of the LITA. C, The
anastomoses between the LITA and additional conduits are performed with continuous 8-0 Prolene
(Ethicon, Inc., Somerville, N.J.) suture. Depending on the size and flow characteristics of the LITA, one
or two Y grafts with either saphenous vein or radial artery can originate from the LITA in this fashion.
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right and left radial arteries. This is essential because the
endoaortic occlusion balloon may migrate and occlude the
innominate artery, and repositioning of the endoaortic
balloon may be necessary. Antegrade cardioplegia was
used for most cases; however, retrograde cardioplegia was
used for complex multivessel procedures. When retro-
grade cardioplegia was used, an 8.5F coronary sinus
catheter (Endocoronary Sinus; Heartport, Inc.) was
placed through an introducer sheath in the right internal
jugular vein and advanced into the coronary sinus under
TEE and fluoroscopic guidance. The coronary sinus cath-
eter was injected with dilute contrast material, and an
angiogram was obtained to confirm its position in the
coronary sinus (Fig. 1). Before placement of the coronary
sinus catheter, the patients were systemically given hepa-
rin 100 U/kg to prevent clot formation on the catheter.
Access to the heart was achieved through a 5 to 8 cm
anterior minithoracotomy. An inframammary incision was
made; the fourth costal cartilage was removed, and the
pleural space was entered (Fig. 2, A). The ITA was
mobilized as a pedicle under direct vision from the
inferior border of the fifth costal cartilage distally to the
subclavian vein proximally. The radial artery or saphenous
vein was harvested in the standard fashion when addi-
tional conduits were needed for multivessel procedures.
Papaverine-soaked gauze pads were placed on the radial
artery during harvesting, and the vessel was gently dis-
tended with dilute papaverine after removal. In addition,
these patients received intravenous calcium channel
blockers during the operation and for 24 hours after the
operation, at which time they received oral calcium chan-
nel blockers.
The ITA was occluded proximally and distally (Fig. 2,
B), and the proximal anastomoses were placed on the
midportion of the LITA with 8-0 polypropylene sutures
(Fig. 2, C). Once the proximal anastomoses were com-
pleted, the LITA was divided distally and gently injected
with dilute papaverine solution and occluded. The peri-
cardium was opened and the LAD was identified. Groin
dissection was carried out simultaneously in preparation
for femoral vessel cannulation. After additional systemic
heparinization, the femoral artery was cannulated through
a transverse arteriotomy with a 23F or 21F dual-limb
arterial cannula (Endoarterial Return; Heartport, Inc.;
Fig. 3). Venous drainage was achieved by advancing a 28F
or 21F long venous cannula (DLP, Inc., Grand Rapids,
Mich.) from the femoral vein into the right atrium under
TEE guidance. The distal tip of the venous cannula was
positioned in the superior vena cava. Venous drainage was
augmented with a centrifugal pump (Medtronic Bio-
Medicus, Eden Prairie, Minn.) in the venous side of the
CPB circuit, which resulted in a well-decompressed heart.
For this reason, the endopulmonary vent (Endopulmo-
nary Vent; Heartport, Inc.), which can be placed via the
jugular vein and into the pulmonary artery, was not used
in most of the Port-Access procedures at this institution.
Next, a 10.5F triple-lumen, endoaortic balloon occlu-
sion catheter (Endoaortic Clamp; Heartport, Inc.) was
inserted through the side port of the femoral artery
cannula (Fig. 4). For the initial five patients, fluoroscopy
was used to advance the endoaortic occlusion balloon up
the descending aorta and into the ascending aorta approx-
imately 2 to 3 cm above the aortic valve. For the most
recent patients, however, TEE was used to position these
catheters and is currently used exclusively for positioning
of the catheters from the femoral vessels. However, when
difficulty is encountered passing the catheters from the
femoral vessels, both fluoroscopy and TEE should be
used. Aortic root and balloon pressure monitoring lines,
aortic root suction, and the cardioplegia line were con-
nected to the lumens of the endoaortic occlusion catheter.
The femoral arterial cannula, femoral venous cannula,
and endoaortic balloon occlusion catheter were all care-
fully inserted and advanced over a guidewire with the
Seldinger technique.
Bypass was initiated and patients were cooled to 25° to
30° C. The target vessels were identified and marked. The
balloon of the endoaortic occlusion catheter was inflated 2
to 3 cm above the aortic valve under TEE guidance (Fig.
5). Early in the series an aortic root angiogram with the
endoaortic occlusion balloon inflated had been obtained;
however, with TEE and bilateral radial artery monitoring,
our experience suggests that the balloon can be ade-
quately positioned and monitored without the routine use
of fluoroscopy or aortic root angiography. Cold blood
cardioplegia was used in all patients. Retrograde cardio-
plegia was administered to two patients through the
coronary sinus catheter. The remainder of the patients
received antegrade cardioplegia. After cardioplegic arrest,
the distal anastomoses were performed with running 7-0
or 8-0 polypropylene sutures with standard instruments.
Additional doses of cardioplegic solution were adminis-
tered after the completion of each distal anastomosis.
Before deflation of the Endoaortic Clamp, a ventricular
pacing wire and a left pleural 32F chest tube were placed.
A decompressed, flaccid heart aids in the placement of the
chest tube and pacing wire.
The Endoaortic Clamp was then deflated; rewarming
was completed, and the patients were weaned from by-
pass. The femoral cannulas were removed and the femoral
vessels were repaired. The thoracotomy incision was
closed in three layers. No attempt was made to approxi-
mate the third and fifth ribs. The patients were reintu-
bated with a single-lumen endotracheal tube and trans-
ported to the cardiac surgery recovery room.
Fig. 3. Illustration of the dual port Endoarterial Return
(Heartport, Inc.) cannula with its obturator. The cannula
is inserted into the femoral artery over a guidewire. One
port is used for peripheral CPB, and the other port is used
to pass the endoaortic occlusion balloon.
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Postoperative course. On arrival in the recovery room,
blood samples, chest radiographs, and electrocardiograms
were obtained on all patients. The patients were extubated
several hours after the operation and were placed in a
chair the evening of the operation when feasible. Chest
tubes were removed the following morning. Patients were
transferred to the surgical floor where early mobilization
and ambulation was encouraged. Before discharge from
the hospital, patients underwent coronary angiography for
evaluation of the CABGs.
Results
Of 32 patients taken to the operating room for the
Port-Access approach, 31 patients underwent Port-
Access CABG. One patient was noted intraopera-
tively at the time of groin dissection to have severe
atherosclerosis of the femoral artery and was con-
verted to minimally invasive direct coronary artery
bypass (MIDCAB). For the Port-Access proce-
dures, the mean CPB time was 83.7 minutes (70%
confidence interval [CI] 5 77.6% to 89.7%); the
mean clamp time was 45.1 minutes (70% CI 5
41.2% to 49.0%);the mean time to extubation was
10.1 hours (70% CI 5 8.3 to 11.9 hours), and the
mean hospital stay was 9.0 days (70% CI 5 7.4 to
10.7 days; median 5 6.5 days; range 3 to 42 days). Of
the 23 patients who were discharged within 7 days of
the operation, 15 were employed and 8 were retired;
the mean time between operation and return to
work for the 15 employed patients was 14.2 days.
There were no deaths, neurologic deficits, myo-
cardial infarctions, or aortic dissections. Conversion
to sternotomy was not required in any case. There
were two reoperations for bleeding (6.4%). One
patient was bleeding from a radial artery side
branch, and the other patient was bleeding from an
LITA side branch. One patient (3.2%) required
reoperation for tamponade on postoperative day 3;
no active bleeding was identified in this patient. One
patient who underwent a triple bypass procedure
was noted on postoperative angiography to have a
severe stenosis in an unbypassed diagonal artery.
The patient was asymptomatic without evidence of
ischemia. Later, however, he experienced the acute
development of severe dyspnea and respiratory fail-
ure; a pulmonary angiogram showed a massive
pulmonary embolus. He underwent emergency me-
dian sternotomy, pulmonary embolectomy, and
grafting of the diagonal coronary artery. Additional
complications included empyema necessitating de-
cortication in one patient (3.2%), effusion necessi-
tating thoracentesis in one patient (3.2%), and
transient atrial fibrillation in one patient (3.2%).
One patient (3.2%) with chronic renal failure had an
infection of the peritoneal dialysis catheter after the
operation and remained in the hospital for 4 weeks.
Before discharge from the hospital, 27 of 31
patients (87%) underwent coronary angiography for
evaluation of the bypass grafts. There were no
complications associated with postoperative angiog-
raphy. Significant spasm was noted in 3 of 10 radial
artery grafts (30%). Angiography revealed patency
of the LITA to LAD coronary artery anastomosis in
26 of 26 grafts (100%) with overall anastomotic
patency in 43 of 44 grafts (97.7%). One radial artery
to RCA anastomosis was occluded. This patient
underwent successful angioplasty and stenting of the
native RCA and remained asymptomatic in the
postoperative period. A postoperative angiogram of
a Port-Access triple bypass procedure is shown in
Fig. 6. The LITA was grafted in a sequential fashion
to the diagonal and LAD coronary artery, and the
Fig. 4. Illustration of the endoaortic occlusion balloon
catheter shows the three lumens. One lumen is used to
inflate the balloon and occlude the aorta. The second
lumen is used to measure the aortic root pressure. The
third lumen is used to deliver antegrade cardioplegia
when indicated. This lumen can also be connected to
suction to vent the aortic root. In addition, the guidewire
used for insertion of the endoaortic occlusion balloon is
passed through this lumen.
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radial artery was grafted from the LITA to the
circumflex artery.
Discussion
CABG via a median sternotomy with CPB is a
well-established procedure and has been shown to
provide excellent long-term graft patency with ac-
ceptable morbidity and mortality rates.1-3 Recently,
however, several alternative and innovative tech-
niques for minimally invasive coronary revascular-
ization have been developed. The early approach to
minimally invasive coronary revascularization in-
volved CABG on the beating heart. The beating
heart technique was initially performed through a
median sternotomy 4-8 and later through a less
invasive minithoracotomy.9-13 Early results have
been encouraging with the limited anterior small
thoracotomy or MIDCAB procedure in select pa-
tients. The technique, however, appears to be appli-
cable only to patients with single-vessel coronary
disease, a group that accounts for a very small
percentage of the overall cardiac surgical popula-
tion. Furthermore, there is clearly a potential for
decreased anastomotic precision with the beating
heart technique through a minithoracotomy, and no
study to date has been published that has used
routine postoperative angiography to evaluate graft
patency in these patients. Similarly, several other
clinical experiences with minimally invasive coro-
nary bypass with anterior mediastinotomies, hemi-
sternotomies, and parasternotomies have been re-
ported without routine angiographic studies to
determine graft patency.14-16
The Port-Access system was developed to allow
surgeons to perform minimally invasive cardiac sur-
gery on an arrested, protected heart through a
minithoracotomy incision. This endovascular system
for CPB and myocardial protection uses femoral
arterial and venous cannulation for peripheral per-
fusion and a transfemoral Endoaortic Clamp for
aortic occlusion and antegrade delivery of cardiople-
gic solution. In addition, a transjugular coronary
sinus catheter can be placed into the coronary sinus
for retrograde cardioplegia when indicated. Finally,
a transjugular Endopulmonary Vent can be ad-
vanced into the pulmonary artery for cardiac vent-
ing. With this newly developed system, the heart can
be stopped, decompressed, and protected, allowing
the surgeon to use standard anastomotic techniques
while working through a minithoracotomy incision.
Before clinical use, the Port-Access system was
tested extensively in the Stanford University and New
York University (NYU) research laboratories.17-19 A
clinical study of Port-Access CABG was initiated at
NYU in October 1996. The purpose of this study was
to determine the safety and efficacy of Port-Access
CABG and to evaluate with angiography the early
graft patency rate with this new approach. Patients
with single or multivessel coronary artery disease with-
out evidence of peripheral vascular disease were con-
sidered for the Port-Access approach. As the cardiol-
ogists at this institution have become more familiar
with the selection criteria for Port-Access surgery, they
have more frequently obtained an aortogram with
runoff during initial cardiac catheterization to evaluate
the aorta, iliac, and femoral arteries for evidence of
atherosclerotic disease.
The Port-Access procedures were performed by
one of four cardiothoracic surgeons trained in the
Port-Access technique (G.H.R., E.A.G., A.C.G.,
S.B.C.) and represent their initial clinical experience
with the Port-Access technique for CABG. Simi-
larly, the transjugular catheters were placed by one
of four anesthesiologists trained in this approach.
Fluoroscopy was used routinely in conjunction with
TEE to place the transjugular coronary sinus cath-
eter when retrograde cardioplegia was indicated.
For this reason, TEE is currently used exclusively at
this institution for positioning of the catheters from
the femoral vessels. When difficulty is encountered
passing the catheters from the femoral vessels, both
Fig. 5. TEE is used to position the endoaortic occlusion
balloon in the ascending aorta. This longitudinal view of
the ascending aorta shows the balloon of the endoaortic
occlusion catheter (EAC) inflated 2 to 3 cm above the
aortic valve (AV). The left atrium (LA) is also seen.
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fluoroscopy and TEE should be used. When the
femoral arterial cannula or Endoaortic Clamp can-
not be easily and atraumatically placed, retrograde
perfusion should be abandoned completely because
the risk of retrograde aortic dissection or stroke may
be significant. Under these circumstances, the tho-
racotomy incision should be extended or a sternot-
omy should be performed, and central aortic cannu-
lation and crossclamping should be used. No
patients in this series required central cannulation
or crossclamping, extension of the thoracotomy, or
conversion to sternotomy.
With the Port-Access approach, single and mul-
tivessel coronary artery bypass procedures were
feasible. All coronary arteries, except the RCA,
were readily accessible through a left anterior
minithoracotomy. In patients requiring CABG to
the proximal RCA, a second right anterior minitho-
racotomy or a standard sternotomy should be used.
The LITA served as the site for proximal anastomo-
sis in all cases of multivessel bypass. This approach
is supported by the work of Calafiore and co-
investigators,20 who used the ITA for inflow for the
radial artery or inferior epigastric artery in 226
patients undergoing myocardial revascularization.
At a mean follow-up of 18.5 months, the cumulative
patency rate of the radial artery grafts was 93.1%
and of the inferior epigastric artery grafts was
95.7%. These authors suggested that it may actually
be better to use the LITA instead of the aorta for
the proximal anastomosis in certain cases. First, the
proximal anastomosis on the ascending aorta may
result in a mismatch between the relative wall
thickness of the conduit and aorta. In addition, the
aortic wall is frequently diseased, especially in el-
derly patients. These conditions could lead to early
graft failure caused by technical factors. Second,
arterial grafts that are placed with the proximal
anastomosis on the ascending aorta are exposed to a
rate of rise of ventricular pressure that is different
from their natural position. This increased wall
stress could result in intimal hyperplasia and be the
basis for early or late graft failure.20
The initial clinical results of the Port-Access
approach are encouraging. Although several pa-
tients with significant complications were hospital-
Fig. 6. Postoperative angiogram of a Port-Access triple-vessel bypass with (A) a sequential LITA
anastomosis to the LAD coronary artery and diagonal (DIAG). The proximal anastomosis between the
LITA and radial artery (RA) is also demonstrated. B, The anastomosis between the RA and circumflex
(CIRC) is widely patent as well.
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ized for 4 to 6 weeks, most patients who underwent
Port-Access CABG were ready for discharge within
3 to 4 days after the procedure. The seemingly long
mean hospital stay of 9.0 days reflects those patients
with protracted hospital courses and the extra hos-
pital day required for postoperative arteriography.
The mean hospital stay for the most recent seven
patients who underwent the Port-Access approach
was 4.2 days. Furthermore, most patients are return-
ing to work within 2 to 3 weeks of their procedure.
There were no deaths in this series. There were
no neurologic deficits, which may be attributed to
careful patient selection and intraoperative evalua-
tion of the aorta with TEE. Furthermore, some
investigators have suggested that aortic occlusion
with an endovascular balloon may be less traumatic
than an external crushing clamp and may result in
fewer strokes.19 In addition, there were no periop-
erative myocardial infarctions, and myocardial pro-
tection during balloon occlusion CPB and cardiople-
gic arrest was excellent. Finally, there were no cases
of aortic dissection with the Port-Access technique
for coronary revascularization.
The major goal of this study was to evaluate the
feasibility and effectiveness of the Port-Access ap-
proach in terms of postoperative graft patency as
determined by angiography, the gold standard for
anastomotic evaluation. Before discharge from the
hospital, 27 of 31 patients (87%) underwent coronary
angiography for evaluation of the CABGs. Three
patients refused postoperative angiography, despite
prior agreement, and one patient who had an empy-
ema did not undergo postoperative catheterization.
Despite several recent reports21, 22 demonstrating ex-
cellent patency rates of the radial artery conduit with
careful handling of the graft during harvesting, gentle
hydrostatic dilation, and extensive use of calcium chan-
nel blockers, angiography in this series demonstrated
significant spasm in 3 of 10 radial artery grafts (30%).
These grafts were treated with intracoronary injections
of nitroglycerin and increasing infusions of calcium
channel blockers with complete resolution of the
spasm. In one of these patients, the diltiazem
(Cardizem) drip had been inadvertently discontinued;
however, the other two patients were given routine
infusions of diltiazem 5 mg/hr.
Angiography revealed patency of the LITA to
LAD coronary artery anastomosis in 26 of 26 grafts
(100%) with an overall anastomotic patency in 43 of
44 grafts (97.7%). One radial artery to RCA graft
was occluded. During careful evaluation of all pre-
operative and postoperative cardiac catheteriza-
tions, it was noted that all coronary artery lesions
considered bypassable preoperatively were success-
fully bypassed with the exception of the diagonal
artery previously discussed. This emphasizes that
the Port-Access technique is widely applicable to
single and multivessel revascularization, that com-
plete revascularization is achievable with this ap-
proach, and that “culprit” vessel bypass is not nec-
essary with the Port-Access system.
Limitations of this study include the relatively
small number of patients presently available for
inclusion and the lack of a prospective clinical trial
comparing the Port-Access approach to the sternot-
omy approach for cardiac surgery. Currently at this
institution, a prospective study comparing Port-
Access coronary and valve procedures to conven-
tional open-chest procedures is underway. That
protocol is designed to compare the procedures with
respect to pain, morbidity, hospital stay, recovery
time, return to work, and cost. Our evolving system
for gathering all relevant cost data was insufficiently
complete at the time of this study to permit com-
prehensive cost analysis. In addition, mediators of
systemic inflammatory response and markers of
nutritional requirements and endocrine response
are being assessed. Finally, the adequacy of cardiac
deairing is being evaluated with the use of TEE,
transcranial Doppler monitoring, and neuropsychi-
atric testing in patients undergoing coronary and
valvular procedures with the Port-Access and me-
dian sternotomy approaches.
These initial results suggest that Port-Access
CABG with an endovascular system for CPB and
cardioplegic arrest can be performed accurately and
safely in appropriately selected patients. This ap-
proach allows for multivessel revascularization on
an arrested, protected heart with a high level of
anastomotic precision and reproducible early graft
patency. On the basis of this early experience,
ongoing clinical trials to further demonstrate the
safety and efficacy of the Port-Access system are
clearly indicated. As experience with the Port-Ac-
cess system grows and its clinical use is expanded,
this technique will be progressively refined, and the
Port-Access approach will become increasingly ap-
plicable to a wide range of cardiac surgical patients.
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Discussion
Dr. Elliot T. Gelfand (Edmonton, Alberta, Canada). Dr.
John Hallett, a vascular surgeon at Mayo Clinic, in his
presidential address to the Midwestern Vascular Society
in September of 1996 commented on the ethics of change
in surgery1; to paraphrase him, he said that if a new
procedure were going to be introduced, where an effec-
tive, durable therapy of reasonable cost already existed, it
must provide superior results at lower cost. If that were
not the case, he went on to say, particularly if a learning
curve were involved, it probably ethically and morally
would not be in the best interest of patients. If the
potential benefits were merely debatable or unproven, the
only course of action before widespread application of this
new technology occurred was to embark on a scientifically
impeccable, carefully monitored clinical study. Dr. Riba-
kove and his colleagues have described the feasibility of
performing coronary surgery through a limited surgical
exposure, aided by endovascular CPB and cardioplegic
arrest. They have shown that in carefully selected patients,
the immediate postoperative results including operative
deaths and early graft patency are good, and perhaps
comparable to results attainable via standard techniques.
In the introductory remarks to the manuscript, anticipated
advantages of this procedure include less pain, shorter
hospital stay and recovery time, and a decrease in overall
cost. In this study, none of these issues have been ad-
dressed, and clearly as mentioned by the authors in the
manuscript and mentioned here as well, a randomized,
prospective study to address these matters as well as
longer term issues is mandatory. I would respectfully
submit that until such time as valid data from prospective
studies is available, this procedure should be viewed as
experimental and widespread application should be un-
dertaken with caution, and I would appreciate comment
on that by Dr. Ribakove.
R E F E R E N C E
1. Hallett JW Jr. Presidential address. Back to the future of
vascular surgery: why certain procedures become obsolete. J
Vasc Surg 1997;25:791-5.
Dr. Ribakove. The cardiac surgery department at NYU
participated in a Food and Drug Administration protocol
that showed the safety of this system. Furthermore, we
have undertaken prospective studies of both the valve and
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CABG in patients undergoing these procedures. Careful
follow-up is essential to eventually show equivalence of
these less-invasive procedures to the gold standard of
open sternum CPB.
Dr. Gelfand. The avoidance of CPB has been a major
focus of many proponents of minimal access coronary
surgery. They would make two points, I think today: first,
that one of the primary reasons to do these kinds of
procedures is to avoid bypass; and second, that precise
and complete revascularization is possible on the beating
heart. How would you counter these arguments?
Dr. Ribakove. Avoidance of CPB as a goal remains
controversial. There is preliminary evidence that less
inflammatory response occurs during these minimally
invasive procedures despite somewhat longer bypass
times. This would implicate the sternotomy as a major
factor for the inflammatory cascade. Further study is
indicated.
The concept that precise and complete revasculariza-
tion can be performed on the beating heart has no
scientific substantiation at this point. Early results of
MIDCAB indicate between a 5% and 20% rate of either
acute closure or problems with the anastomosis. This, of
course, is for single-vessel bypass to the LAD coronary
artery.
Dr. Gelfand. In this highly selected group of patients
who would be considered by most of us to be the most
straightforward candidates for surgical revascularization,
are the described complication rates and lengths of hos-
pital stay justified? Do you feel that a mean CPB time of
81 minutes and a mean clamp time of 44 minutes to do an
average of 1.6 grafts per patient is appropriate? And, if in
fact, there is a learning curve, would you want to be on
one?
Dr. Ribakove. As with any new procedure, there is a
learning curve. Although I might not want to be a patient
on this learning curve, I also probably would not have
wanted to be an early patient for standard CABG, valve
operations, and a whole host of other procedures. How-
ever, we should not use learning curves as an excuse to
stop potential advances in surgery or medicine.
As we move along the learning curve, our operative
times continue to shorten. Overall complication rates are
low and continue to improve.
Dr. Gelfand. Where do you anticipate that the cost
savings will be? Is it in the cost of disposables or lengths of
stay, or is there added anesthesia or operating room time
in view of the fact that double-lumen tubes need to be
placed? If you are using retrograde cardioplegia, percuta-
neous coronary sinus catheters need to be placed. Where
are the cost savings anticipated?
Dr. Ribakove. As I mentioned during my talk, we are
beginning to undertake a cost analysis of these proce-
dures. Cost savings may come in the form of shorter
hospital stay, but this remains to be seen. One bit of
optimistic data is that in uncomplicated cases, the mean
time back to work is 14 days, which could represent a
significant overall cost savings.
Dr. Fabrizio M. Follis (Albuquerque, N.M.). The patient
who was explored for bleeding, did you go back through
the minithoracotomy or through a median sternotomy?
Dr. Ribakove. Through the thoracotomy.
Dr. Thomas A. Pfeffer (Los Angeles, Calif.). One of the
reported benefits of the so-called minimally invasive pro-
cedures is the shortened hospital length of stay. Certainly
even with conventional CPB with the single ITA to the
LAD coronary artery, one could anticipate a hospital stay
of 4 days or under; your mean hospital stay was 8 days.
Can you share with us what the reason for the longer
hospital stay in these patients?
Dr. Ribakove. Median hospital stay was 6 days. For our
last 10 patients it is about 4 days. Hospitalizations are
lengthened by repeat cardiac catheterization. In addition,
there have been several extended hospital stays for unre-
lated problems.
Dr. Pfeffer. My second question relates to your 30%
incidence of radial artery spasm. Was this a clinical
manifestation with electrocardiographic changes or an-
gina or a radiographic finding? Did you have a protocol of
calcium channel blockers for these patients?
Dr. Ribakove. No patients in this study had postopera-
tive ischemia. These findings were purely on an angio-
graphic basis. All patients with radial artery grafts are kept
on a protocol of intraoperative and postoperative intrave-
nous and oral calcium blockers.
Presently, we do not know if there will be any clinical
manifestations of this problem. We will, however, con-
tinue to closely follow these patients.
Dr. William I. Brenner (Hackensack, N.J.). We have
heard, as we stand on the brink of possibly starting to use
this technology, that the patient is in the operating room
at 7 am and that the surgeon does not come into the
operating room until 10:30 am. I am concerned, if this is
correct, about our anesthesia colleagues in cardiac anes-
thesia. With declining reimbursement, how do we get
people to go along, come on board, and stay in an
operating room so many hours to do basically a two-
bypass procedure?
Dr. Ribakove. Those estimates of starting times are
completely false. The placement of the coronary sinus
catheter is the only anesthesia procedure that adds signif-
icant time, and usually it is not used for CABG. Addition-
ally, as the anesthesiologist gains experience, the catheter
placement time shortens.
Finally, opening and closing times in these procedures
are faster, which also helps to reduce operating room
time.
Dr. Edward D. Verrier (Seattle, Wash.). A few years ago,
the Cleveland Clinic showed that the use of an ITA,
particularly in redos to supply blood to the entire anterior
wall of the myocardium sometimes was not an adequate
conduit in terms of the delivery of coronary blood flow. In
this approach to multivessel disease, you are taking all of
your grafts off of the ITA pedicle. Do you have concern or
do you have data that would suggest that you can com-
pletely revascularize the myocardium based on one ITA
proximal?
Dr. Ribakove. This was our first approach to multivessel
revascularization and initial data from stress testing indi-
cate these grafts are adequate. However, we have had the
same concerns and more recently are adapting techniques
to take proximals off the ascending aorta. Also, vascular
stapling devices may enable us to do this even more easily
in the future.
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